RxDoctor Payments Data

Jorge Rodriguez, MD

General Practice · Saint Cloud, FLNPI 1689111411

Payments from drug & device makers

$963in general payments, 2019–2025

Across 60 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$425
  • AstraZeneca$112
  • Johnson & Johnson$89
  • Novo Nordisk$78
  • Eisai Inc.$63
  • Esperion Therapeutics, Inc.$30
  • plus $166 from 8 others

What the payments were for

  • Food & beverage$963100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$963 in reported general payments places this provider in the 75th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$23,737
Medicare patients
66
Services billed
427

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide191$276,121
EliquisApixaban76$83,838
JardianceEmpagliflozin65$65,892
MounjaroTirzepatide34$59,960
FarxigaDapagliflozin Propanediol49$54,462
JanuviaSitagliptin Phosphate32$39,129
TradjentaLinagliptin24$27,604
TrulicityDulaglutide17$27,133
RybelsusSemaglutide11$22,719
EntrestoSacubitril/Valsartan13$18,783
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$18,567
QuliptaAtogepant13$15,015
XareltoRivaroxaban17$14,910
VascepaIcosapent Ethyl22$13,341
LinzessLinaclotide18$10,362

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$78$298,840202 claims
AstraZenecaFarxiga$112$54,46249 claims
AbbVieQulipta, Linzess, Alphagan P, Synthroid$17$33,52370 claims
Johnson & JohnsonXarelto$89$14,91017 claims
Astellas Pharma US IncMyrbetriq$18$7,67315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,901 general practice providers in Florida.

Other general practice in Saint Cloud

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →